Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

Medclair receives a new order worth approximately 12 MSEK in the UK

MAR

Medclair has received a new order from a leading player in the recycling sector. The order value amounts to approximately 12 MSEK and pertains to the UK market. Parts of the order include an installation in Scotland, which means that Medclair is establishing itself in a new geographical market.

Through the new order, Medclair continues to gain ground in the recycling sector, a segment where the company has built a stable and growing customer base in several European countries in recent years. With the installation in Scotland, Medclair's technology for the recycling sector is now in place in England, Scotland, Ireland, Belgium, France, Denmark, and Sweden.

The order confirms the demand Medclair sees in the recycling segment and strengthens the company's position as an established provider of solutions for nitrous oxide destruction for players in waste management and recycling in the UK and the rest of Europe.

"Taking on Scotland as a new market is clear proof that our technology for safe and sustainable nitrous oxide management is in broad demand within the recycling sector, both in the UK and in the rest of Europe. Recycling has in a short time developed into one of our most important growth areas, and together with dental and healthcare, we now have three stable business areas – industry, dental, and healthcare – to rely on in our continued expansion," says Jonas Lundh, CEO of Medclair.

Medclair's three business areas – industry, dental, and healthcare – provide the company with a broader revenue base and reduce its dependence on individual segments or markets. The recycling sector, which is part of the industry business area, has grown over the past year to become a significant part of the order intake and contributes to spreading the company's geographical and commercial risk.

Jonas Lundh
CEO
Medclair AB

Datum 2026-08-20, kl 08:32
Källa MFN